Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Stenosis | 13 | 2013 | 56 | 2.920 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2018 | 43 | 1.850 |
Why?
|
| Stroke | 12 | 2014 | 545 | 1.770 |
Why?
|
| Temporal Lobe | 3 | 2017 | 41 | 1.660 |
Why?
|
| Acoustic Stimulation | 4 | 2018 | 125 | 1.390 |
Why?
|
| Allostasis | 3 | 2017 | 11 | 1.320 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 10 | 2014 | 32 | 1.280 |
Why?
|
| Military Personnel | 2 | 2018 | 85 | 1.190 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2011 | 45 | 1.060 |
Why?
|
| Blood Flow Velocity | 9 | 2012 | 59 | 1.040 |
Why?
|
| Heart Rate | 4 | 2017 | 315 | 0.850 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2013 | 40 | 0.850 |
Why?
|
| Ankle Brachial Index | 2 | 2011 | 37 | 0.780 |
Why?
|
| Baroreflex | 3 | 2017 | 84 | 0.770 |
Why?
|
| Brain | 6 | 2018 | 930 | 0.770 |
Why?
|
| Brain Ischemia | 3 | 2014 | 136 | 0.740 |
Why?
|
| Female | 34 | 2018 | 18164 | 0.730 |
Why?
|
| Humans | 48 | 2018 | 29093 | 0.720 |
Why?
|
| Cerebrovascular Circulation | 2 | 2012 | 95 | 0.710 |
Why?
|
| Male | 29 | 2018 | 17807 | 0.670 |
Why?
|
| Autonomic Nervous System | 2 | 2017 | 42 | 0.660 |
Why?
|
| Electroencephalography | 3 | 2017 | 71 | 0.650 |
Why?
|
| Middle Aged | 21 | 2018 | 10829 | 0.630 |
Why?
|
| Adult | 16 | 2018 | 8420 | 0.610 |
Why?
|
| Nerve Net | 1 | 2018 | 115 | 0.610 |
Why?
|
| Headache | 1 | 2017 | 74 | 0.590 |
Why?
|
| Migraine Disorders | 1 | 2017 | 58 | 0.580 |
Why?
|
| Models, Theoretical | 1 | 2017 | 126 | 0.560 |
Why?
|
| Videoconferencing | 2 | 2013 | 6 | 0.560 |
Why?
|
| Remote Consultation | 2 | 2013 | 10 | 0.560 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 13 | 0.550 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 1 | 2015 | 8 | 0.550 |
Why?
|
| Stress, Psychological | 2 | 2017 | 208 | 0.550 |
Why?
|
| Ischemic Attack, Transient | 3 | 2011 | 46 | 0.550 |
Why?
|
| Ultrasonography, Doppler, Color | 3 | 2006 | 17 | 0.550 |
Why?
|
| Dominance, Cerebral | 1 | 2015 | 11 | 0.530 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 48 | 0.510 |
Why?
|
| Electric Stimulation | 1 | 2015 | 102 | 0.510 |
Why?
|
| Hot Flashes | 1 | 2015 | 46 | 0.510 |
Why?
|
| Neural Pathways | 1 | 2015 | 97 | 0.510 |
Why?
|
| Depression | 2 | 2015 | 380 | 0.500 |
Why?
|
| Hemianopsia | 1 | 2014 | 5 | 0.490 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 787 | 0.490 |
Why?
|
| Citalopram | 1 | 2014 | 5 | 0.490 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 10 | 0.490 |
Why?
|
| Brain Chemistry | 1 | 2014 | 30 | 0.490 |
Why?
|
| Carotid Artery, Common | 2 | 2006 | 37 | 0.480 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 35 | 0.480 |
Why?
|
| Registries | 3 | 2011 | 278 | 0.470 |
Why?
|
| Hyperglycemia | 1 | 2014 | 82 | 0.470 |
Why?
|
| Aged | 20 | 2014 | 9487 | 0.470 |
Why?
|
| Ocular Motility Disorders | 1 | 2013 | 5 | 0.460 |
Why?
|
| Carotid Arteries | 4 | 2012 | 97 | 0.450 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 172 | 0.450 |
Why?
|
| Cerebrovascular Disorders | 4 | 2016 | 48 | 0.420 |
Why?
|
| Thailand | 4 | 2013 | 4 | 0.410 |
Why?
|
| Aged, 80 and over | 11 | 2015 | 3717 | 0.410 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2011 | 11 | 0.400 |
Why?
|
| Pilot Projects | 3 | 2017 | 469 | 0.400 |
Why?
|
| Time Management | 1 | 2010 | 9 | 0.390 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 150 | 0.380 |
Why?
|
| Chi-Square Distribution | 5 | 2013 | 293 | 0.370 |
Why?
|
| North Carolina | 5 | 2017 | 1423 | 0.360 |
Why?
|
| Intracranial Embolism | 1 | 2008 | 13 | 0.320 |
Why?
|
| Blood Pressure | 4 | 2015 | 804 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 871 | 0.300 |
Why?
|
| Stents | 2 | 2008 | 171 | 0.300 |
Why?
|
| Risk Factors | 9 | 2013 | 3531 | 0.290 |
Why?
|
| Hyperemia | 1 | 2006 | 10 | 0.290 |
Why?
|
| Sensitivity and Specificity | 6 | 2012 | 532 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 1 | 2006 | 39 | 0.290 |
Why?
|
| Prevalence | 5 | 2013 | 896 | 0.290 |
Why?
|
| Aging | 1 | 2012 | 881 | 0.280 |
Why?
|
| Accreditation | 2 | 2016 | 14 | 0.270 |
Why?
|
| Ophthalmic Artery | 2 | 2002 | 9 | 0.270 |
Why?
|
| Ambulatory Care Facilities | 2 | 2016 | 64 | 0.260 |
Why?
|
| Adolescent | 4 | 2015 | 3254 | 0.260 |
Why?
|
| Cerebral Angiography | 4 | 2011 | 51 | 0.260 |
Why?
|
| Medicare | 2 | 2016 | 186 | 0.240 |
Why?
|
| Logistic Models | 4 | 2011 | 727 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 3 | 0.220 |
Why?
|
| Angiography | 1 | 2003 | 75 | 0.220 |
Why?
|
| Early Diagnosis | 4 | 2011 | 61 | 0.220 |
Why?
|
| Area Under Curve | 2 | 2017 | 85 | 0.220 |
Why?
|
| Embolism, Air | 1 | 2002 | 5 | 0.220 |
Why?
|
| Jugular Veins | 1 | 2002 | 26 | 0.220 |
Why?
|
| Mass Screening | 3 | 2010 | 223 | 0.220 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2002 | 5 | 0.220 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 863 | 0.210 |
Why?
|
| Anterior Cerebral Artery | 1 | 2002 | 2 | 0.210 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 5 | 0.210 |
Why?
|
| Carotid Artery, Internal | 1 | 2002 | 29 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 30 | 0.210 |
Why?
|
| Prospective Studies | 6 | 2011 | 2019 | 0.210 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 68 | 0.200 |
Why?
|
| Therapeutic Touch | 2 | 2011 | 10 | 0.190 |
Why?
|
| Ultrasonography | 2 | 2016 | 345 | 0.190 |
Why?
|
| Tunica Intima | 2 | 2012 | 59 | 0.190 |
Why?
|
| Sex Factors | 2 | 2012 | 631 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 637 | 0.170 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3111 | 0.160 |
Why?
|
| Vasopressins | 1 | 2017 | 17 | 0.160 |
Why?
|
| Interleukin-1 | 1 | 2017 | 33 | 0.160 |
Why?
|
| Interleukin-10 | 1 | 2017 | 30 | 0.160 |
Why?
|
| Epinephrine | 1 | 2017 | 41 | 0.160 |
Why?
|
| Brain Mapping | 1 | 2018 | 182 | 0.160 |
Why?
|
| Endarterectomy, Carotid | 3 | 2008 | 29 | 0.160 |
Why?
|
| Veterans | 1 | 2017 | 50 | 0.150 |
Why?
|
| Norepinephrine | 1 | 2017 | 73 | 0.150 |
Why?
|
| Hemodynamics | 3 | 2002 | 148 | 0.150 |
Why?
|
| Disease Progression | 2 | 2017 | 572 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2017 | 225 | 0.150 |
Why?
|
| Forecasting | 1 | 2017 | 133 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 232 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2015 | 3099 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2017 | 119 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 726 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2017 | 118 | 0.140 |
Why?
|
| Angiotensin II | 1 | 2017 | 279 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 1218 | 0.140 |
Why?
|
| Posture | 1 | 2015 | 53 | 0.140 |
Why?
|
| Angiotensin I | 1 | 2017 | 262 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2014 | 859 | 0.130 |
Why?
|
| Neurophysiology | 1 | 2015 | 9 | 0.130 |
Why?
|
| Research Design | 1 | 2017 | 286 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2017 | 1687 | 0.130 |
Why?
|
| Young Adult | 2 | 2012 | 2402 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2017 | 422 | 0.130 |
Why?
|
| Menopause | 1 | 2015 | 86 | 0.120 |
Why?
|
| Risk Assessment | 5 | 2011 | 1305 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 48 | 0.120 |
Why?
|
| Reference Values | 2 | 2012 | 224 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2014 | 61 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 88 | 0.120 |
Why?
|
| Benchmarking | 1 | 2013 | 25 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2014 | 105 | 0.110 |
Why?
|
| Atherosclerosis | 2 | 2016 | 693 | 0.110 |
Why?
|
| Time Factors | 4 | 2013 | 2001 | 0.110 |
Why?
|
| Collateral Circulation | 2 | 2002 | 8 | 0.110 |
Why?
|
| Linear Models | 2 | 2003 | 426 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 231 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2013 | 113 | 0.110 |
Why?
|
| Cerebral Arteries | 2 | 2009 | 18 | 0.100 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 493 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 142 | 0.100 |
Why?
|
| Holistic Health | 1 | 2011 | 6 | 0.100 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2011 | 110 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2010 | 30 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 64 | 0.100 |
Why?
|
| Faculty, Nursing | 1 | 2010 | 1 | 0.100 |
Why?
|
| United States | 4 | 2016 | 3630 | 0.100 |
Why?
|
| Pruritus | 1 | 2011 | 58 | 0.090 |
Why?
|
| Community Health Services | 1 | 2010 | 54 | 0.090 |
Why?
|
| Radiology | 1 | 2010 | 37 | 0.090 |
Why?
|
| Leadership | 1 | 2010 | 34 | 0.090 |
Why?
|
| HIV Infections | 1 | 2014 | 335 | 0.090 |
Why?
|
| Burnout, Professional | 1 | 2010 | 44 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 447 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 53 | 0.090 |
Why?
|
| Anxiety | 1 | 2010 | 159 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2010 | 178 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 154 | 0.080 |
Why?
|
| Transportation of Patients | 1 | 2008 | 20 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 251 | 0.080 |
Why?
|
| Patient Admission | 1 | 2008 | 53 | 0.080 |
Why?
|
| Angioplasty | 1 | 2008 | 31 | 0.080 |
Why?
|
| Age Factors | 1 | 2011 | 1108 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 359 | 0.080 |
Why?
|
| Hospitalization | 1 | 2010 | 417 | 0.080 |
Why?
|
| Quinolines | 1 | 2007 | 27 | 0.080 |
Why?
|
| Heptanoic Acids | 1 | 2007 | 28 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 2007 | 36 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 326 | 0.070 |
Why?
|
| Pyrroles | 1 | 2007 | 55 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 109 | 0.070 |
Why?
|
| ROC Curve | 2 | 2009 | 149 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2007 | 52 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 157 | 0.070 |
Why?
|
| Cholesterol | 1 | 2007 | 229 | 0.070 |
Why?
|
| Ethnic Groups | 1 | 2008 | 440 | 0.070 |
Why?
|
| Expert Systems | 1 | 2004 | 3 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2004 | 70 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 6 | 0.060 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 27 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 46 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2003 | 18 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2006 | 1167 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 73 | 0.060 |
Why?
|
| Amobarbital | 1 | 2002 | 2 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 18 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2002 | 8 | 0.050 |
Why?
|
| Epilepsies, Partial | 1 | 2002 | 9 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 242 | 0.050 |
Why?
|
| Contrast Media | 1 | 2002 | 123 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 27 | 0.050 |
Why?
|
| Arm | 1 | 2002 | 31 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2002 | 39 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2002 | 454 | 0.050 |
Why?
|
| Child | 1 | 2006 | 2219 | 0.050 |
Why?
|
| Prognosis | 2 | 2014 | 1362 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2016 | 149 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 31 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 50 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2014 | 96 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 464 | 0.030 |
Why?
|
| Workflow | 1 | 2013 | 20 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 332 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 59 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 70 | 0.030 |
Why?
|
| Software | 1 | 2013 | 109 | 0.030 |
Why?
|
| Mental Recall | 1 | 2010 | 52 | 0.020 |
Why?
|
| Telephone | 1 | 2010 | 48 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2011 | 94 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 71 | 0.020 |
Why?
|
| Motivation | 1 | 2010 | 102 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 274 | 0.020 |
Why?
|
| Health Behavior | 1 | 2010 | 214 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 208 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 709 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1013 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 211 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2007 | 501 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 257 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2004 | 3 | 0.020 |
Why?
|
| Software Design | 1 | 2004 | 5 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 10 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2004 | 25 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2004 | 18 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 82 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2004 | 27 | 0.020 |
Why?
|
| Probability | 1 | 2004 | 150 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2004 | 128 | 0.020 |
Why?
|
| Thalamus | 1 | 2004 | 39 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 25 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 6 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2002 | 59 | 0.010 |
Why?
|
| Memory | 1 | 2002 | 187 | 0.010 |
Why?
|
| Motor Activity | 1 | 2002 | 310 | 0.010 |
Why?
|